BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 105 filers reported holding BIOSCRIP INC in Q3 2017. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,738,000 | -13.7% | 767,000 | -25.1% | 0.11% | -3.5% |
| Q3 2018 | $3,172,000 | -53.6% | 1,023,379 | -56.2% | 0.11% | -52.5% |
| Q2 2018 | $6,842,000 | -11.0% | 2,335,000 | -25.3% | 0.24% | -9.8% |
| Q1 2018 | $7,685,000 | -15.5% | 3,124,000 | 0.0% | 0.27% | -25.7% |
| Q4 2017 | $9,091,000 | +198.6% | 3,124,000 | +182.2% | 0.36% | +161.3% |
| Q3 2017 | $3,045,000 | -15.5% | 1,107,166 | -16.6% | 0.14% | -28.6% |
| Q2 2017 | $3,605,000 | +7.6% | 1,327,966 | -32.6% | 0.19% | +48.8% |
| Q1 2017 | $3,351,000 | +63.5% | 1,971,228 | 0.0% | 0.13% | +53.6% |
| Q4 2016 | $2,050,000 | -64.0% | 1,971,228 | 0.0% | 0.08% | -68.3% |
| Q3 2016 | $5,697,000 | -25.2% | 1,971,228 | -34.0% | 0.26% | -11.4% |
| Q2 2016 | $7,616,000 | +1370.3% | 2,986,800 | +4165.5% | 0.30% | +1007.4% |
| Q4 2013 | $518,000 | -95.3% | 70,022 | -94.4% | 0.03% | -94.7% |
| Q3 2013 | $10,967,000 | – | 1,249,041 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RIVULET CAPITAL, LLC | 1,400,000 | $11,676,000 | 9.66% |
| DSC Advisors, L.P. | 3,150,000 | $26,272,000 | 7.40% |
| Consonance Capital Management LP | 3,950,839 | $32,950,000 | 4.90% |
| NFC Investments, LLC | 951,580 | $7,936,000 | 3.88% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 2,090,789 | $17,437,000 | 3.07% |
| KEANE CAPITAL MANAGEMENT INC | 310,000 | $2,585,000 | 2.41% |
| First Washington CORP | 454,200 | $3,788,000 | 2.12% |
| GLENHILL ADVISORS LLC | 2,486,490 | $20,737,000 | 1.68% |
| ARDSLEY ADVISORY PARTNERS LP | 1,500,000 | $12,510,000 | 1.60% |
| True Bearing Asset Management LP | 357,161 | $2,979,000 | 1.55% |